Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7029)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2016 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yazici O, Sendur MAN, Ozdemir N, Aksoy S. Targeted therapies in gastric cancer and future perspectives. World J Gastroenterol 2016; 22(2): 471-489 [PMID: 26811601 DOI: 10.3748/wjg.v22.i2.471] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i2/471.htm |
| Number | Citing Articles |
| 1 |
Shih‐Chiang Huang, Kwai‐Fong Ng, Ta‐Sen Yeh, Chi‐Tung Cheng, Jie‐Sian Lin, Yu‐Jen Liu, Huei‐Chieh Chuang, Tse‐Ching Chen. Subtraction of Epstein–Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases. International Journal of Cancer 2019; 145(12): 3218 doi: 10.1002/ijc.32215
|
| 2 |
Xi Wei, Wei Duan, Ying Li, Sheng Zhang, Xiaojie Xin, Lei Sun, Ming Gao, Qing Li, Dong Wang. AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy. Oncotarget 2016; 7(23): 34430 doi: 10.18632/oncotarget.9119
|
| 3 |
Zuhua Chen, Wenwen Huang, Tiantian Tian, Wanchun Zang, Jingyuan Wang, Zhentao Liu, Zhongwu Li, Yumei Lai, Zhi Jiang, Jing Gao, Lin Shen. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer. Journal of Hematology & Oncology 2018; 11(1) doi: 10.1186/s13045-018-0563-y
|
| 4 |
G. G. Khakimova, T. N. Zabotina, A. A. Tryakin, A. A. Borunova, T. V. Davidova, A. E. Kalinin, Yu. V. Vakhabova, E. N. Zakharova, D. V. Tabakov. Analysis of systemic immunity and inflammation in the prognosis of gastric adenocarcinoma. Advances in Molecular Oncology 2020; 7(1): 38 doi: 10.17650/2313-805X-2020-7-1-38-46
|
| 5 |
Hiromi Nagata, Hironori Tsujimoto, Yoshihisa Yaguchi, Keita Kouzu, Yujiro Itazaki, Yusuke Ishibashi, Satoshi Tsuchiya, Takao Sugihara, Nozomi Ito, Manabu Harada, Shinsuke Nomura, Yoshitaka Utsumi, Hideyuki Shimazaki, Yoji Kishi, Hideki Ueno. Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-0774-7
|
| 6 |
Burak Bilgin, Mehmet A.N. Sendur, Muhammed Bülent Akıncı, Didem Şener Dede, Bülent Yalçın. Targeting the PD-1 pathway: a new hope for gastrointestinal cancers. Current Medical Research and Opinion 2017; 33(4): 749 doi: 10.1080/03007995.2017.1279132
|
| 7 |
Chenming Li, Shasha Liu, Qian Zhang, Dongdong Wan, Rong Shen, Zhong Wang, Yuee Li, Bin Hu. Combining Raman spectroscopy and machine learning to assist early diagnosis of gastric cancer. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2023; 287: 122049 doi: 10.1016/j.saa.2022.122049
|
| 8 |
Muhammad Aqeel Aslam, Cuili Xue, Yunsheng Chen, Amin Zhang, Manhua Liu, Kan Wang, Daxiang Cui. Breath analysis based early gastric cancer classification from deep stacked sparse autoencoder neural network. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83184-2
|
| 9 |
Anna Valentini, Federica Di Pinto, Sergio Coletta, Vito Guerra, Raffaele Armentano, Maria Caruso. Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status. Oncology Letters 2019; doi: 10.3892/ol.2019.10513
|
| 10 |
Xue Huang, Du He, Lin Lai, Jun Chen, Yukun Zhang, Huilin Mao. Evaluation of clinical efficacy, adverse reactions, and safety of PD-1 inhibitors combined with chemotherapy when treating advanced gastric cancer. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03011-y
|
| 11 |
Zhicheng Huang, Amin Zhang, Qian Zhang, Daxiang Cui. Nanomaterial-based SERS sensing technology for biomedical application. Journal of Materials Chemistry B 2019; 7(24): 3755 doi: 10.1039/C9TB00666D
|
| 12 |
Yijia Lin, Huashe Wang, Xinyou Wang, Miao Li, Honglei Chen, Junsheng Peng. Low expression of RecQ‑like helicase 5 is associated with poor prognosis in patients with gastric cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.11137
|
| 13 |
Jing Zhang, Lei Guo, Xiuyun Liu, Wenbin Li, Jianming Ying. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma. Oncotarget 2017; 8(6): 10264 doi: 10.18632/oncotarget.14382
|
| 14 |
Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, Antonio Cubillo Gracian, Richard A. Hubner, Jean-Luc Van Laethem, Carolina Muriel López, Maria Alsina, Frederico Longo Muñoz, Johanna Bendell, Irfan Firdaus, Wells Messersmith, Zhan Ye, Adedigbo A. Fasanmade, Hadi Danaee, Thea Kalebic. Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C. Investigational New Drugs 2017; 35(2): 235 doi: 10.1007/s10637-017-0439-y
|
| 15 |
C. Coutzac, S. Pernot, N. Chaput, A. Zaanan. Immunotherapy in advanced gastric cancer, is it the future?. Critical Reviews in Oncology/Hematology 2019; 133: 25 doi: 10.1016/j.critrevonc.2018.10.007
|
| 16 |
Ling Li, Jia-wei Li, Xiao-jie Jin, Cheng-hao Li, Jun-jie Li, Ming Fang, Lu Qiu, Si-yu Wang, Wei Chu, Yong-qi Liu. A combination therapy of ingredients from TCM for the prevention and treatment of gastric cancer by targeting HER2/ PD-L1. Pharmacological Research - Modern Chinese Medicine 2021; 1: 100021 doi: 10.1016/j.prmcm.2021.100021
|
| 17 |
Chen Xu, Yalan Liu, Dongxian Jiang, Qian Li, Xiaowen Ge, Ying Zhang, Jie Huang, Jieakesu Su, Yuan Ji, Jun Hou, Shaohua Lu, Yingyong Hou, Tianshu Liu. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. Oncotarget 2017; 8(20): 33185 doi: 10.18632/oncotarget.16567
|
| 18 |
Jingjing Bao, Xiaoqin Jiang, Xiaowei Zhu, Guihong Dai, Rongrong Dou, Xinyun Liu, Haihui Sheng, Zongmin Liang, Hong Yu. Clinical significance of ubiquilin 1 in gastric cancer. Medicine 2018; 97(3): e9701 doi: 10.1097/MD.0000000000009701
|
| 19 |
Chin-Hsiao Tseng. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules 2021; 11(7): 1022 doi: 10.3390/biom11071022
|
| 20 |
Zheng-Rong Zhou, Pan Huang, Guang-Hao Song, Zhuang Zhang, Ke An, Han-Wen Lu, Xiao-Li Ju, Wei Ding. Comparative proteomic analysis of rats subjected to water immersion and restraint stress as an insight into gastric ulcers. Molecular Medicine Reports 2017; 16(4): 5425 doi: 10.3892/mmr.2017.7241
|
| 21 |
Zuhua Chen, Lin Shen. Advantages and limitations in the establishment and utilization of patient-derived xenografts in gastric cancer. Oncology and Translational Medicine 2017; 3(1): 3 doi: 10.1007/s10330-016-0187-7
|
| 22 |
Qiong Luo, Suyun Zhang, Donghuan Zhang, Fang Yuan, Xiangqi Chen, Sheng Yang. Expression of ASAP1 and FAK in gastric cancer and its clinicopathological significance. Oncology Letters 2020; 20(1): 974 doi: 10.3892/ol.2020.11612
|
| 23 |
Gulnoz G. Khakimova, Yana A. Bozhchenko, Tatyana N. Zabotina, Alexey A. Tryakin. The identification of tumor-infiltrating lymphocytes in patients with stomach cancer. Journal of Modern Oncology 2021; 23(2): 307 doi: 10.26442/18151434.2021.2.200328
|
| 24 |
Tao Chen, Kun Wang, Xianzhou Tong. In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene. Oncology Reports 2017; 38(3): 1663 doi: 10.3892/or.2017.5823
|
| 25 |
Kuai Yu, Linju Kuang, Tianmei Fu, Congkai Zhang, Yuru Zhou, Chao Zhu, Qian Zhang, Zhanglin Zhang, Aiping Le. CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.697748
|
| 26 |
Ibrahim Halil Erdogdu. MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/4785098
|
| 27 |
Juan Wang, Min Yang, Quan Wang, Gang Ji. Comparison of Early Oral Feeding With Traditional Oral Feeding After Total Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01194
|